Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874716-22-000038
Filing Date
2022-11-01
Accepted
2022-11-01 16:33:30
Documents
101
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idxx-20220930.htm   iXBRL 10-Q 2761903
2 EX-31.1 idxx2022q310-qexhibit311.htm EX-31.1 10997
3 EX-31.2 idxx2022q310-qexhibit312.htm EX-31.2 11013
4 EX-32.1 idxx2022q310-qexhibit321.htm EX-32.1 6000
5 EX-32.2 idxx2022q310-qexhibit322.htm EX-32.2 6331
11 GRAPHIC idxx-20220930_g1.jpg GRAPHIC 3233
  Complete submission text file 0000874716-22-000038.txt   10780820

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20220930.xsd EX-101.SCH 61220
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT idxx-20220930_cal.xml EX-101.CAL 94005
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20220930_def.xml EX-101.DEF 283403
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20220930_lab.xml EX-101.LAB 714786
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20220930_pre.xml EX-101.PRE 483053
95 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20220930_htm.xml XML 2095157
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19271 | Film No.: 221350915
SIC: 2835 In Vitro & In Vivo Diagnostic Substances